New clinical results showed Cardiologs Technologies’ artificial intelligence software was an effective tool for the analysis of electrocardiogram (ECG) waveforms, significantly reducing the measured false positive rate of atrial fibrillation in recordings by remotely monitored implantable loop recorders (ILR).
Boston-based Cardiologs claims to be the first company to receive regulatory clearance for a medical device powered by deep learning technology, with its Cardiologs ECG analysis platform being CE marked in August 2016. The system was
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?